On 1/3/25, Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 14.4%, closing at $7.62. Moreover, exceptionally high trading volume at 249% of normal accompanied the advance. The stock has been strong relative to the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Lifecore Biomedical has a very low Appreciation Score of 1 but a slightly positive Power Rating of 68, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment